Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis.

Yamashita T, Kamada H, Kanasaki S, Maeda Y, Nagano K, Abe Y, Inoue M, Yoshioka Y, Tsutsumi Y, Katayama S, Inoue M, Tsunoda S.

Pharmazie. 2013 Dec;68(12):969-73.

PMID:
24400444
2.

Soluble epidermal growth factor receptor isoforms in non-small cell lung cancer tissue and in blood.

Maramotti S, Paci M, Miccichè F, Ciarrocchi A, Cavazza A, De Bortoli M, Vaghi E, Formisano D, Canovi L, Sgarbi G, Bongarzone I.

Lung Cancer. 2012 Jun;76(3):332-8. doi: 10.1016/j.lungcan.2011.11.018. Epub 2011 Dec 15.

PMID:
22177532
3.

Characterization of soluble and exosomal forms of the EGFR released from pancreatic cancer cells.

Adamczyk KA, Klein-Scory S, Tehrani MM, Warnken U, Schmiegel W, Schnölzer M, Schwarte-Waldhoff I.

Life Sci. 2011 Aug 29;89(9-10):304-12. doi: 10.1016/j.lfs.2011.06.020. Epub 2011 Jul 6.

PMID:
21763319
4.

Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patients.

Jantus-Lewintre E, Sirera R, Cabrera A, Blasco A, Caballero C, Iranzo V, Rosell R, Camps C.

Clin Lung Cancer. 2011 Sep;12(5):320-7. doi: 10.1016/j.cllc.2011.03.031. Epub 2011 May 11.

PMID:
21729651
5.

Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade.

Wu W, Onn A, Isobe T, Itasaka S, Langley RR, Shitani T, Shibuya K, Komaki R, Ryan AJ, Fidler IJ, Herbst RS, O'Reilly MS.

Mol Cancer Ther. 2007 Feb;6(2):471-83.

6.

Proteomic identification of exosomal LRG1: a potential urinary biomarker for detecting NSCLC.

Li Y, Zhang Y, Qiu F, Qiu Z.

Electrophoresis. 2011 Aug;32(15):1976-83. doi: 10.1002/elps.201000598. Epub 2011 May 9.

PMID:
21557262
7.

Exosomal microRNA: a diagnostic marker for lung cancer.

Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH.

Clin Lung Cancer. 2009 Jan;10(1):42-6. doi: 10.3816/CLC.2009.n.006.

PMID:
19289371
8.

Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.

Hyogotani A, Ito K, Yoshida K, Izumi H, Kohno K, Amano J.

Clin Lung Cancer. 2012 Sep;13(5):375-84. doi: 10.1016/j.cllc.2011.11.006. Epub 2012 Jan 27.

PMID:
22284440
9.

Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy.

Ciardiello F, Bianco R, Caputo R, Caputo R, Damiano V, Troiani T, Melisi D, De Vita F, De Placido S, Bianco AR, Tortora G.

Clin Cancer Res. 2004 Jan 15;10(2):784-93.

10.

Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer.

Sasaki H, Yukiue H, Mizuno K, Sekimura A, Konishi A, Yano M, Kaji M, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y.

Int J Clin Oncol. 2003 Apr;8(2):79-82.

PMID:
12720099
12.

Reproducibility of immunohistochemical scoring for epidermal growth factor receptor expression in non-small cell lung cancer: round robin test.

Rüschoff J, Kerr KM, Grote HJ, Middel P, von Heydebreck A, Alves VA, Baldus SE, Büttner R, Carvalho L, Fink L, Jochum W, Lo AW, López-Ríos F, Marx A, Molina TJ, Olszewski WT, Rieker RJ, Volante M, Thunnissen E, Wrba F, Celik I, Störkel S.

Arch Pathol Lab Med. 2013 Sep;137(9):1255-61. doi: 10.5858/arpa.2012-0605-OA. Epub 2012 Dec 27.

PMID:
23270410
13.

Magnetic bead-based isolation of exosomes.

Oksvold MP, Neurauter A, Pedersen KW.

Methods Mol Biol. 2015;1218:465-81. doi: 10.1007/978-1-4939-1538-5_27.

PMID:
25319668
14.

Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.

Miura N, Nakamura H, Sato R, Tsukamoto T, Harada T, Takahashi S, Adachi Y, Shomori K, Sano A, Kishimoto Y, Ito H, Hasegawa J, Shiota G.

Cancer Sci. 2006 Dec;97(12):1366-73.

15.

EGFR expression as an ancillary tool for diagnosing lung cancer in cytology specimens.

Wei EX, Anga AA, Martin SS, Jackson JG, Nordberg ML, Herrera GA, Turbat-Herrera EA.

Mod Pathol. 2007 Sep;20(9):905-13. Epub 2007 Jul 20.

16.

Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.

Rusch V, Baselga J, Cordon-Cardo C, Orazem J, Zaman M, Hoda S, McIntosh J, Kurie J, Dmitrovsky E.

Cancer Res. 1993 May 15;53(10 Suppl):2379-85.

17.
18.

Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.

Jia RP, Xu LW, Su Q, Zhao JH, Li WC, Wang F, Xu Z.

Asian J Androl. 2008 Sep;10(5):758-64. doi: 10.1111/j.1745-7262.2008.00423.x.

19.

Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer.

Brugger W, Triller N, Blasinska-Morawiec M, Curescu S, Sakalauskas R, Manikhas GM, Mazieres J, Whittom R, Ward C, Mayne K, Trunzer K, Cappuzzo F.

J Clin Oncol. 2011 Nov 1;29(31):4113-20. doi: 10.1200/JCO.2010.31.8162. Epub 2011 Oct 3. Erratum in: J Clin Oncol. 2011 Dec 10;29(35):4725.

20.

AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.

Traxler P, Allegrini PR, Brandt R, Brueggen J, Cozens R, Fabbro D, Grosios K, Lane HA, McSheehy P, Mestan J, Meyer T, Tang C, Wartmann M, Wood J, Caravatti G.

Cancer Res. 2004 Jul 15;64(14):4931-41.

Items per page

Supplemental Content

Write to the Help Desk